drugset / Trial / NCT02305056

Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)

NCT02305056 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to follow tumoral proteins metabolism by in vivo no radioactive isotopic tagging (carbon 13 and nitrogen 15).

Timeline

Start
2014-09
Primary completion
2018-01-30
Completion
2018-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject C13 N15 Valine Unknown — —

Indications